Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia

Qing Lan, Chao A. Hsiung, Keitaro Matsuo, +128

Nature Genetics

Genome-wide Association StudyTobacco ControlEpidemiologyMedicineGenetics +12

Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study

Silvia Novello, Julien Mazières, In‐Jae Oh, +12

Annals of Oncology

Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients

Young-Wook Kim, Peter S. Hammerman, Jaegil Kim, +30

Journal of Clinical Oncology

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types

Joshua N. Sampson, William A. Wheeler, Meredith Yeager, +402

JNCI Journal of the National Cancer Institute

Pulmonary actinomycosis during the first decade of 21st century: cases of 94 patients

So Ri Kim, Lae Young Jung, In‐Jae Oh, +13

BMC Infectious Diseases

Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistance

Jeong Eun Lee, Hee Sun Park, Dahye Lee, +14

Biochemical and Biophysical Research Communications

Egfr-tki ResistanceMedicineLung AdenocarcinomaBronchial NeoplasmTumor Suppressor +5

Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses

Sunmin Kim, Jisun Oh, Yu‐Il Kim, +6

BMC Pulmonary Medicine

<scp>G</scp>enetic variants associated with longer telomere length are associated with increased lung cancer risk among never‐smoking women in Asia: a report from the female lung cancer consortium in Asia

Mitchell J. Machiela, Chao A. Hsiung, Xiao‐Ou Shu, +129

International Journal of Cancer

GPx3-mediated redox signaling arrests the cell cycle and acts as a tumor suppressor in lung cancer cell lines

Byung Chull An, Yoo Duk Choi, In‐Jae Oh, +3

PLoS ONE

Lung InflammationCell DeathCell CycleCancer BiologyRedox Biology +19

Retreatment of gefitinib in patients with non-small-cell lung cancer who previously controlled to gefitinib: A single-arm, open-label, phase II study

In‐Jae Oh, Hee‐Jung Ban, Kyu‐Sik Kim, +1

Lung Cancer

Non-small-cell Lung CancerMedicineCancer ManagementPathologyPhase Ii Study +4